Select Medical (SEM) Institutional Ownership

During the previous two years, 265 institutional investors and hedge funds held shares of Select Medical. The most heavily invested institutionals were BlackRock Inc. ($526.95M), Price T Rowe Associates Inc. MD ($329.59M), Vanguard Group Inc. ($239.64M), State Street Corp ($143.83M), Camber Capital Management LP ($129.03M), Dimensional Fund Advisors LP ($83.53M), and T. Rowe Price Investment Management Inc. ($83.30M).Learn more on SEM's institutional investors.

89.48% of Select Medical stock is owned by institutional investors. Learn more on SEM's institutional investor holdings.

Of the 214 institutional investors that purchased Select Medical stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Norges Bank ($3.03M), Hood River Capital Management LLC ($2.23M), Point72 Asset Management L.P. ($1.76M), The Manufacturers Life Insurance Company ($1.54M), Vanguard Group Inc. ($1.19M), Invesco Ltd. ($864.85K), and Bridgeway Capital Management LLC ($746.62K).

Institutional investors have bought a total of 26,374,850 shares in the last 24 months. This purchase volume represents approximately $650.76M in transactions.

Of the 126 institutional investors that sold Select Medical stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: LSV Asset Management ($4.21M), T. Rowe Price Investment Management Inc. ($1.86M), Victory Capital Management Inc. ($1.40M), Camber Capital Management LP ($750K), Assenagon Asset Management S.A. ($429.88K), Bank of New York Mellon Corp ($420.38K), and FMR LLC ($363.84K).

Institutional investors have sold a total of 13,529,114 shares in the last 24 months. This volume of shares sold represents approximately $351.44M in transactions.